PhD in Molecular Pathology in Glasgow United Kingdom | University of Glasgow

Our Molecular Pathology research concept originates from tissue-based studies that form the foundation for Precision Medicine. By deciphering disease mechanisms, we can advance novel treatments. Molecular and non-invasive biomarkers may improve therapy selection through more accurate response predictions. Our work spans various conditions including cancer, inflammatory disorders, heart diseases, and more. Projects may focus on fundamental biological inquiries (basic research) or address clinical knowledge gaps and diagnostic requirements (applied research).
Pathology research fundamentally explores disease processes. With over two centuries of pathology education and investigation, our current Department at Queen Elizabeth University Hospital (established May 2012) ranks among Europe's largest. Supported by £3.4 million in MRC/EPSRC funding for the Glasgow Molecular Pathology Node (2015-2019), we're translating Precision Medicine research into diagnostic applications.
Our research teams operate from University of Glasgow facilities in the Laboratory Medicine Building at Queen Elizabeth University Hospital. We provide Molecular Pathology research opportunities for both medical and life sciences students, leveraging strong ties with Glasgow Tissue Research Facility (GTRF) and partnerships across Medical, Veterinary, and Life Sciences colleges. Our PhD programs train students in cutting-edge tissue research techniques for Molecular Pathology. Projects may tackle significant biological challenges or clinical demands, utilizing model systems, patient samples, imaging data, or clinical information. Supervision comes from University of Glasgow and NHS academic staff, collaborating with research institutes like Cancer Sciences, Infection/Immunity/Inflammation, and Cardiovascular/Medical Sciences.